pegs1, for that reason (a risk) I'm very happy to see RAM finally forging ahead with his own Aviptadil trials outside of the USA. It's going to make the FDA look very foolish for letting the ROW get ahead of it with Aviptadil.
It's like Dr Joey has stated...it's not a matter of "if", it's a matter of "when".
Market Data 
Markets 
AI
